Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Abdulrasool LI"'
Autor:
Topletz-Erickson AR; Clinical Pharmacology and Pharmacometrics, Seagen Inc., 21823 30th Drive SE, Bothell, WA, 98021, USA., Mayor JG; Clinical Development, Seagen Inc., Bothell, WA, USA., Liu HT; Global Safety Risk Management, Seagen Inc., Bothell, WA, USA., Abdulrasool LI; Global Safety Risk Management, Seagen Inc., Bothell, WA, USA., Endres CJ; Clinical Pharmacology and Pharmacometrics, Seagen Inc., 21823 30th Drive SE, Bothell, WA, 98021, USA. CEndres@seagen.com.
Publikováno v:
Drugs in R&D [Drugs R D] 2023 Dec; Vol. 23 (4), pp. 411-419. Date of Electronic Publication: 2023 Sep 26.
Autor:
Topletz-Erickson AR; Clinical Pharmacology and Pharmacometrics, Seagen Inc., 21823 30th Drive SE, Bothell, WA, 98021, USA., Lee AJ; Translational ADME and PKPD, Seagen Inc., Bothell, WA, USA., Mayor JG; Clinical Development, Seagen Inc., Bothell, WA, USA., Sun H; Translational ADME and PKPD, Seagen Inc., Bothell, WA, USA., Abdulrasool LI; Clinical Development, Seagen Inc., Bothell, WA, USA., Rustia EL; Clinical Development, Seagen Inc., Bothell, WA, USA.; Gilead Sciences, Seattle, WA, USA., Walker LN; Clinical Development, Seagen Inc., Bothell, WA, USA.; Harpoon Therapeutics, South San Francisco, CA, USA., Endres CJ; Clinical Pharmacology and Pharmacometrics, Seagen Inc., 21823 30th Drive SE, Bothell, WA, 98021, USA. CEndres@seagen.com.
Publikováno v:
Clinical pharmacokinetics [Clin Pharmacokinet] 2022 Dec; Vol. 61 (12), pp. 1761-1770. Date of Electronic Publication: 2022 Dec 05.
Autor:
Topletz-Erickson A; Clinical Pharmacology and Pharmacometrics, Seagen Inc., 21823 30th Drive SE, Bothell, WA, 98021, USA., Lee A; Translational ADME and PKPD, Seagen Inc., Bothell, WA, USA., Rustia EL; Clinical Development, Seagen Inc., Bothell, WA, USA.; Gilead Sciences, Seattle, WA, USA., Sun H; Translational ADME and PKPD, Seagen Inc., Bothell, WA, USA., Mayor JG; Clinical Development, Seagen Inc., Bothell, WA, USA., Abdulrasool LI; Clinical Development, Seagen Inc., Bothell, WA, USA., Walker L; Clinical Development, Seagen Inc., Bothell, WA, USA., Endres CJ; Clinical Pharmacology and Pharmacometrics, Seagen Inc., 21823 30th Drive SE, Bothell, WA, 98021, USA. CEndres@seagen.com.
Publikováno v:
Clinical pharmacokinetics [Clin Pharmacokinet] 2022 Oct; Vol. 61 (10), pp. 1417-1426. Date of Electronic Publication: 2022 Aug 06.
Autor:
Topletz-Erickson AR; Clinical Pharmacology, Seattle Genetics, Bothell, Washington, USA., Lee AJ; DMPK, Seattle Genetics, Bothell, Washington, USA., Mayor JG; Development, Seattle Genetics, Bothell, Washington, USA., Rustia EL; Development, Seattle Genetics, Bothell, Washington, USA., Abdulrasool LI; Development, Seattle Genetics, Bothell, Washington, USA., Wise AL; PRA Health Sciences, Lenexa, Kansas, USA., Dailey B; PRA Health Sciences, Lenexa, Kansas, USA., DeChenne S; Alturas Analytics, Inc., Moscow, Idaho, USA., Walker LN; Development, Seattle Genetics, Bothell, Washington, USA., Alley SC; Translational Sciences, Seattle Genetics, Bothell, Washington, USA., Endres CJ; Clinical Pharmacology, Seattle Genetics, Bothell, Washington, USA.
Publikováno v:
Journal of clinical pharmacology [J Clin Pharmacol] 2021 Apr; Vol. 61 (4), pp. 461-471. Date of Electronic Publication: 2020 Sep 28.